Impact Factor:6.549
 Scopus Suggested Journal: UNDER REVIEW for TITLE INCLUSSION

International Journal
of Computer Engineering in Research Trends (IJCERT)

Scholarly, Peer-Reviewed, Open Access and Multidisciplinary


Welcome to IJCERT

International Journal of Computer Engineering in Research Trends. Scholarly, Peer-Reviewed,Open Access and Multidisciplinary

ISSN(Online):2349-7084                 Submit Paper    Check Paper Status    Conference Proposal

Back to Current Issues

Ensemble based Model for Diabetes Prediction and COVID-19 Mortality Risk Assessment in Diabetic Patients

Dr. Sushma Jaiswal, Ms. Priyanka Gupta, , ,
Affiliations
Guru ghasidas University Koni, Bilaspur (C.G.)
:10.22362/ijcert/2023/v10/i03/v10i0302


Abstract
Millions of individuals worldwide suffer from the chronic ailment known as diabetes, which can harm several organs including the kidneys, eyes, and heart arteries. Diabetes patients are those who are most impacted by COVID 19. This study explores the use of machine learning techniques for predicting diabetes and assessing COVID-19 mortality risks for diabetic patients. The study was conducted on a diabetes and covid 19 datasets containing demographic and clinical features of patients. On both the datasets, the machine learning techniques Support Vector Machine, Random Forest, Multilayer perceptron, naïve bayes and Logistic Regression are used. additionally, their combination is employed to improve the performances of the models. The accuracy, precision, recall, and F1-score of these algorithms were evaluated to determine their performance in predicting diabetes and covid 19. By making this enhancement, healthcare services could use less time, labour, and resources while also making decisions with more reliability. The results of the study showed that the ensemble model had the highest accuracy in predicting diabetes and covid 19. The study also found that older age, higher HbA1c levels, and the presence of comorbidities were significant predictors of mortality risk in diabetic patients with COVID-19. The study concludes that machine learning techniques can be useful in predicting diabetes and assessing COVID-19 mortality risks in diabetic patients, and these findings could aid in developing effective preventive and treatment strategies for diabetes and COVID-19.


Citation
Dr. Sushma Jaiswal,Ms. Priyanka Gupta."Ensemble based Model for Diabetes Prediction and COVID-19 Mortality Risk Assessment in Diabetic Patients ". International Journal of Computer Engineering In Research Trends (IJCERT) ,ISSN:2349-7084 ,Vol.10, Issue 03,pp.99-106, March - 2023, URL :https://ijcert.org/ems/ijcert_papers/V10I0302.pdf,


Keywords : Machine LearningHealthcareEnsemble Model

References
[1]	T. Beghriche, M. Djerioui, Y. Brik, B. Attallah, and S. B. Belhaouari, “An Efficient Prediction System for Diabetes Disease Based on Deep Neural Network,” Complexity, vol. 2021, 2021, doi: 10.1155/2021/6053824.
[2]	U. M. Butt, S. Letchmunan, M. Ali, F. H. Hassan, A. Baqir, and H. H. R. Sherazi, “Machine Learning Based Diabetes Classification and Prediction for Healthcare Applications,” J Healthc Eng, vol. 2021, 2021, doi: 10.1155/2021/9930985.
[3]	M. M. Bukhari, B. F. Alkhamees, S. Hussain, A. Gumaei, A. Assiri, and S. S. Ullah, “An Improved Artificial Neural Network Model for Effective Diabetes Prediction,” Complexity, vol. 2021, 2021, doi: 10.1155/2021/5525271.
[4]	P. Rajendra and S. Latifi, “Prediction of diabetes using logistic regression and ensemble techniques,” Computer Methods and Programs in Biomedicine Update, vol. 1, p. 100032, 2021, doi: 10.1016/j.cmpbup.2021.100032.
[5]	L. Roncon, M. Zuin, G. Rigatelli, and G. Zuliani, “Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome,” J Clin Virol, vol. 127, Jun. 2020, doi: 10.1016/J.JCV.2020.104354.
[6]	H. Khadem, H. Nemat, M. R. Eissa, J. Elliott, and M. Benaissa, “COVID-19 mortality risk assessments for individuals with and without diabetes mellitus: Machine learning models integrated with interpretation framework,” Comput Biol Med, vol. 144, May 2022, doi: 10.1016/J.COMPBIOMED.2022.105361.
[7]	G. Li, Q. Deng, J. Feng, F. Li, N. Xiong, and Q. He, “Clinical Characteristics of Diabetic Patients with COVID-19,” J Diabetes Res, vol. 2020, 2020, doi: 10.1155/2020/1652403.
[8]	C. Huang et al., “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China,” The Lancet, vol. 395, no. 10223, pp. 497–506, Feb. 2020, doi: 10.1016/S0140-6736(20)30183-5.
[9]	J. jin Zhang et al., “Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China,” Allergy, vol. 75, no. 7, pp. 1730–1741, Jul. 2020, doi: 10.1111/ALL.14238.
[10]	J. Wu et al., “Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection,” Diabetes Obes Metab, vol. 22, no. 10, pp. 1907–1914, Oct. 2020, doi: 10.1111/DOM.14105.
[11]	X. W. Xu et al., “Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series,” BMJ, vol. 368, Feb. 2020, doi: 10.1136/BMJ.M606.
[12]	G. P. Fadini, M. L. Morieri, E. Longato, and A. Avogaro, “Prevalence and impact of diabetes among people infected with SARS-CoV-2,” J Endocrinol Invest, vol. 43, no. 6, pp. 867–869, Jun. 2020, doi: 10.1007/S40618-020-01236-2.
[13]	S. Richardson et al., “Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area,” JAMA, vol. 323, no. 20, pp. 2052–2059, May 2020, doi: 10.1001/JAMA.2020.6775.
[14]	M. R. Mehra, S. S. Desai, S. Kuy, T. D. Henry, and A. N. Patel, “Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19,” N Engl J Med, vol. 382, no. 25, p. e102, Jun. 2020, doi: 10.1056/NEJMOA2007621.
[15]	I. Huang, M. A. Lim, and R. Pranata, “Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 14, no. 4, pp. 395–403, Jul. 2020, doi: 10.1016/J.DSX.2020.04.018.
[16]	L. Zhu et al., “Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes,” Cell Metab, vol. 31, no. 6, pp. 1068-1077.e3, Jun. 2020, doi: 10.1016/J.CMET.2020.04.021.
[17]	G. P. Fadini et al., “Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration,” Diabetes Res Clin Pract, vol. 168, Oct. 2020, doi: 10.1016/J.DIABRES.2020.108374.
[18]	Y. Mahamat-Saleh et al., “Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies,” BMJ Open, vol. 11, no. 10, Oct. 2021, doi: 10.1136/BMJOPEN-2021-052777.
[19]	S. Jaiswal and P. Gupta, “MLP-DTP: Performance Evaluation of Diabetes Class Prediction,” IEMECON 2021 - 10th International Conference on Internet of Everything, Microwave Engineering, Communication and Networks, 2021, doi: 10.1109/IEMECON53809.2021.9689183.
[20]	H. T. Abbas et al., “Predicting long-term type 2 diabetes with support vector machine using oral glucose tolerance test,” PLoS One, vol. 14, no. 12, Dec. 2019, doi: 10.1371/JOURNAL.PONE.0219636.
[21]	K. Vijiyakumar, B. Lavanya, I. Nirmala, and S. Sofia Caroline, “Random Forest Algorithm for the Prediction of Diabetes,” undefined, Mar. 2019, doi: 10.1109/ICSCAN.2019.8878802.
[22]	M. Alehegn, R. Joshi, and P. Mulay, “Diabetes Analysis And Prediction Using Random Forest, KNN, Naïve Bayes, And J48: An Ensemble Approach,” undefined, 2019.
[23]	H. Salem, M. Y. Shams, O. M. Elzeki, M. A. Elfattah, J. F. Al?amri, and S. Elnazer, “Fine-Tuning Fuzzy KNN Classifier Based on Uncertainty Membership for the Medical Diagnosis of Diabetes,” Applied Sciences 2022, Vol. 12, Page 950, vol. 12, no. 3, p. 950, Jan. 2022, doi: 10.3390/APP12030950.
[24]	S. Islam Ayon and Md. Milon Islam, “Diabetes Prediction: A Deep Learning Approach,” International Journal of Information Engineering and Electronic Business, vol. 11, no. 2, pp. 21–27, Mar. 2019, doi: 10.5815/IJIEEB.2019.02.03.
[25]	A. K. Dwivedi, “Analysis of computational intelligence techniques for diabetes mellitus prediction,” Neural Comput Appl, vol. 30, no. 12, pp. 3837–3845, Dec. 2018, doi: 10.1007/S00521-017-2969-9/FIGURES/7.


DOI Link : https://doi.org/10.22362/ijcert/2023/v10/i03/v10i0302

Download :
  V10I0302.pdf


Refbacks : Currently there are no Refbacks

Announcements


Authors are not required to pay any article-processing charges (APC) for their article to be published open access in Journal IJCERT. No charge is involved in any stage of the publication process, from administrating peer review to copy editing and hosting the final article on dedicated servers. This is free for all authors. 

News & Events


Latest issue :Volume 10 Issue 1 Articles In press

A plagiarism check will be implemented for all the articles using world-renowned software. Turnitin.


Digital Object Identifier will be assigned for all the articles being published in the Journal from September 2016 issue, i.e. Volume 3, Issue 9, 2016.


IJCERT is a member of the prestigious.Each of the IJCERT articles has its unique DOI reference.
DOI Prefix : 10.22362/ijcert


IJCERT is member of The Publishers International Linking Association, Inc. (“PILA”)


Emerging Sources Citation Index (in process)


IJCERT title is under evaluation by Scopus.


Key Dates


☞   INVITING SUBMISSIONS FOR THE NEXT ISSUE :
☞   LAST DATE OF SUBMISSION : 31st March 2023
☞  SUBMISSION TO FIRST DECISION :
In 7 Days
☞  FINAL DECISION :
IN 3 WEEKS FROM THE DAY OF SUBMISSION

Important Announcements


All the authors, conference coordinators, conveners, and guest editors kindly check their articles' originality before submitting them to IJCERT. If any material is found to be duplicate submission or sent to other journals when the content is in the process with IJCERT, fabricated data, cut and paste (plagiarized), at any stage of processing of material, IJCERT is bound to take the following actions.
1. Rejection of the article.
2. The author will be blocked for future communication with IJCERT if duplicate articles are submitted.
3. A letter regarding this will be posted to the Principal/Director of the Institution where the study was conducted.
4. A List of blacklisted authors will be shared among the Chief Editors of other prestigious Journals
We have been screening articles for plagiarism with a world-renowned tool: Turnitin However, it is only rejected if found plagiarized. This more stern action is being taken because of the illegal behavior of a handful of authors who have been involved in ethical misconduct. The Screening and making a decision on such articles costs colossal time and resources for the journal. It directly delays the process of genuine materials.

Citation Index


Citations Indices All
Citations 1026
h-index 14
i10-index 20
Source: Google Scholar

Acceptance Rate (By Year)


Acceptance Rate (By Year)
Year Rate
2021 10.8%
2020 13.6%
2019 15.9%
2018 14.5%
2017 16.6%
2016 15.8%
2015 18.2%
2014 20.6%

Important Links



Conference Proposal




DOI:10.22362/ijcert